Patent · US Expired

2-amino-4-phenylquinazoline derivatives and the use thereof as HSP90 modulators

US7947696B2 · kind B2 · utility

5Cited by

2References

19Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Hans-Michael Eggenweiler · Darmstadt, DE
Michael Wolf · Darmstadt, DE
Hans-Peter Buchstaller · Griesheim, DE

Key dates

Filing date	Apr 24, 2006
Grant date	May 24, 2011
Priority date	—
Expiry date	Apr 24, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel phenylquinazoline derivatives of the formula (I), in which R1, R2, R3, R4 and R5 have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.